Home › Crohn's Disease › Virginia › Roanoke
Crohn's Disease clinical trials in Roanoke, VA
4 studies for Crohn's Disease are looking for participants at sites in and around Roanoke (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Gastroenterology Consultants of Southwest Virginia., Roanoke
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Carilion Children's Tanglewood Center, Roanoke
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
RecruitingPhase 3
- Carilion Children's Tanglewood Center, Roanoke
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2
- Gastroenterology Consultants of Southwest Virginia., Roanoke
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY33 studies
- St. Louis, MO19 studies
- Miami, FL19 studies
- Orlando, FL19 studies
- Boston, MA18 studies
- Houston, TX17 studies
- Atlanta, GA16 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- Cleveland, OH15 studies
- Colorado Springs, CO14 studies
- San Antonio, TX14 studies
Other studies in Roanoke
- Colorectal Cancer10 studies
- Non-Small Cell Lung Cancer8 studies
- Heart Failure8 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Prostate Cancer6 studies
- Stomach Cancer4 studies
- Small Cell Lung Cancer4 studies
- Diabetic Foot4 studies
- Ulcerative Colitis4 studies
- Melanoma4 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.